The heightened expression of necroptosis-associated molecules such as RIPK1 and RIPK3, along with the activation of necroptosis facilitated by the RIPK1/RIPK3 pathway, significantly contribute to the upregulation of IL-17, thereby inducing chronic inflammation in psoriasis [23, 24]. Here, IL17A is linked to psoriasis.